PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood

PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier

Published:2015-08 Issue: Volume:211 Page:134-143
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Fornaguera C.^ORCID,Dols-Perez A.^ORCID,Calderó G.,García-Celma M.J.,Camarasa J.,Solans C.

Funder

MINECO

Generalitat de Catalunya

CIBER-BBN

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference67 articles.

1. Neurotherapeutic applications of nanoparticles in Alzheimer's disease;Sahni;J. Control. Release,2011

2. Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine;Farlow;Clin. Ther.,2001

3. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood–brain barrier;Tosi;Nanomedicine,2011

4. Nanomedicine for the treatment of Alzheimer's disease;Gregori;Nanomedicine (Lond),2015

5. Galantamine — a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease;Lilienfeld;CNS Drug Rev.,2006

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surface decoration of PLGA nanoparticles enables efficient transport of floxuridine oligomers into mammalian cells;Reactive and Functional Polymers;2024-09

2. Engineering ternary systems as non-viral vehicles for transporting floxuridine oligomer;European Polymer Journal;2024-08

3. Nanofibers in Drug Delivery Systems: A Comprehensive Scientific Review of Recent Approaches;International Journal of Pharmaceutical Investigation;2024-07-01

4. Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands;Journal of Nanobiotechnology;2024-05-17

5. Nucleic acid-loaded poly(beta-aminoester) nanoparticles for cancer nano-immuno therapeutics: the good, the bad, and the future;Drug Delivery and Translational Research;2024-05-03